Disclosures for "Implementing the CMS GUIDE Dementia Care Model in a Community Neurology Practice with Digital Tools, Standardized Scales, and Embedded Clinical Trial Recruitment"
-
Dr. Sahagian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Sahagian has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Sahagian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sahagian has received intellectual property interests from a discovery or technology relating to health care.
-
Vidar Vignisson has stock in Intraneuron, LLC. Vidar Vignisson has received intellectual property interests from a discovery or technology relating to health care.
-
An immediate family member of Mr. Vidarsson has stock in Intraneuron, LLC. An immediate family member of Mr. Vidarsson has received intellectual property interests from a discovery or technology relating to health care.
-
Mr. Rojas has nothing to disclose.
-
An immediate family member of Mr. Inocelda has received personal compensation for serving as an employee of Orthofix.